Urology Division News
MRI Now Used to Detect Prostate Cancer
Prostate cancer is the most common cancers among men and according to the Centers for Disease Control and Prevention (CDC), it's one of the deadliest.
"Prostate cancer is probably 60 to 70% of patients I see," said Dr. Shaheen Alanee, Director of SIU Urologic Oncology.
Dr. Alanee says developing prostate cancer depends primarily on your race, age, and your family history.
"If you have a male who has a father or a brother that was diagnosed with prostate cancer at an early age, then his chance of having prostate cancer is two to four times higher than everyone else in the population," said Dr. Alanee.
Dr. Ahmed El-Zawahry, Assistant Professor in the Division of Urology, recently received the Best Reviewer Award from among 3,000 fellow reviewers by the editors of The Journal of Urology. The selection was based on the volume, timeliness and quality of his reviews.
Congratulations, Dr. El-Zawahry.
- SIU Med School, St. John’s Hospital Use MRI for Accurate, Painless Prostate Cancer Detection.
Men undergoing an evaluation for possible prostate cancer now have access to an advanced technique to manage the disease: Magnetic Resonance Imaging (MRI) of the prostate. The MRI program is a new partnership of a urological oncologist from Simmons Cancer Institute, School of Medicine and radiologists from St. John’s Hospital.
MRI of the prostate is developing as a powerful tool to better detect cancer within the prostate. It also allows for safe, conservative management of prostate cancer in cases of low volume, low risk cancer tumors. Undergoing a painless MRI creates a more accurate diagnosis while being less invasive than the traditional ultrasound-guided biopsy of the prostate.
“There is increasing evidence that using the MRI before a biopsy can accurately identify patients who require immediate biopsies and those who could be deferred,” said Dr. Shaheen Alanee, head of Urologic Oncology and assistant professor of surgery at SIU. Alanee recently trained at Memorial Sloan Kettering Cancer Center. “The partnership with St. John’s radiology brings more accurate monitoring to the Springfield area. Our findings are already detecting cancer in areas a biopsy did not.”
Alanee and St. John’s radiologist Dr. Vincent Zata have taken special training in France to read these prostate MRIs. They have been amazed at how much more accurate the findings are than the traditional biopsy. Based on MRI findings, prostate biopsies may still be needed. St. John’s may purchase equipment to computerize the biopsy process.
“The potential of MRI in prostate cancer detection and management seems unlimited,” Zata said. “As the technology develops, more uses for MRI are being identified. It’s not too far in the future that we may be able to substitute prostate biopsy with a combination of blood tests and MRI imaging, thus saving our patients the discomfort of an invasive procedure.”
- World Experts and Androgen Study Group Petition JAMA to Retract Misleading Article on Testosterone Therapy
BOSTON, March, 25, 2014 /PRNewswire/ -- Three professional medical societies and a highly distinguished international group of over 130 scientists and concerned physicians have petitioned the Journal of the American Medical Association to retract the article that precipitated recent concerns regarding cardiovascular risks with testosterone therapy. more...
- Prostate Cancer, Active Surveillance, and you!
Dr. Kevin McVary, Professor and Chair, Division of Urology - read pdf here
- What Your Erection Says About Your Health
Article by Tobias Köhler, MD concerning Erectile Dysfunction - click here
- The Urology- Cardiology Connection
Tobias Köhler, MD - click here
- AUA Meeting - Low Testosterone: Proper Diagnosis A presentation by Dr.Köhler
- Plan to offer OTC CIallis by Lilley and Sanofi. Article with Dr.McVary in Wall Street Journal